Related Experiment Video

Updated: Aug 25, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

Cardiovascular implications of HIV-associated dyslipidemic lipodystrophy

Rajagopal V Sekhar1, Farook Jahoor, Henry J Pownall

  • 1Division of Endocrinology, Baylor College of Medicine, 719E, One Baylor Plaza, Houston, TX 77030, USA.

Current Atherosclerosis Reports
|April 8, 2004
PubMed

Insights

HIV-associated dyslipidemic lipodystrophy (HADL) is a metabolic syndrome increasing cardiovascular disease risk. This review explores HADL

Area of Science:

  • Metabolic disorders
  • Immunology
  • Cardiovascular medicine

Background:

  • HIV infection is associated with a unique metabolic syndrome, HIV-associated dyslipidemic lipodystrophy (HADL).
  • HADL presents with central fat redistribution, severe dyslipidemia, and insulin resistance.
  • This syndrome significantly increases the risk of cardiovascular disease (CVD).

Purpose of the Study:

  • To review the metabolic, molecular, and cytokine derangements contributing to cardiovascular disease in HADL.
  • To elucidate the factors driving CVD development in HIV-infected patients with HADL.

Main Methods:

  • Review of existing literature on HADL.
  • Analysis of metabolic, molecular, and cytokine profiles in HADL patients.
  • Examination of the interplay between HIV, antiretroviral drugs, and CVD pathogenesis.

Main Results:

  • HADL involves complex interactions between HIV components, antiretroviral therapies, and host inflammatory responses.
  • Accelerated lipolysis, dyslipidemia, and lipotoxic insulin resistance are key features.
  • Vascular inflammation is a significant contributor to CVD risk in HADL.

Conclusions:

  • Understanding the multifaceted derangements in HADL is crucial for managing CVD risk.
  • Targeting metabolic, molecular, and inflammatory pathways may offer therapeutic strategies.
  • Further research is needed to fully elucidate the mechanisms linking HADL to cardiovascular complications.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...